These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31273195)

  • 1. Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis.
    Yang YS; Xie J; Wang D; Kim JM; Tai PWL; Gravallese E; Gao G; Shim JH
    Nat Commun; 2019 Jul; 10(1):2958. PubMed ID: 31273195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy.
    Yang YS; Xie J; Chaugule S; Wang D; Kim JM; Kim J; Tai PWL; Seo SK; Gravallese E; Gao G; Shim JH
    Mol Ther Methods Clin Dev; 2020 Jun; 17():922-935. PubMed ID: 32405514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schnurri-3 inhibition suppresses bone and joint damage in models of rheumatoid arthritis.
    Stavre Z; Kim JM; Yang YS; Nündel K; Chaugule S; Sato T; Park KH; Gao G; Gravallese EM; Shim JH
    Proc Natl Acad Sci U S A; 2023 May; 120(19):e2218019120. PubMed ID: 37141171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering a targeted and safe bone anabolic gene therapy to treat osteoporosis in alveolar bone loss.
    Lin C; Yang YS; Ma H; Chen Z; Chen D; John AA; Xie J; Gao G; Shim JH
    Mol Ther; 2024 Sep; 32(9):3080-3100. PubMed ID: 38937970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting skeletal endothelium to ameliorate bone loss.
    Xu R; Yallowitz A; Qin A; Wu Z; Shin DY; Kim JM; Debnath S; Ji G; Bostrom MP; Yang X; Zhang C; Dong H; Kermani P; Lalani S; Li N; Liu Y; Poulos MG; Wach A; Zhang Y; Inoue K; Di Lorenzo A; Zhao B; Butler JM; Shim JH; Glimcher LH; Greenblatt MB
    Nat Med; 2018 Jun; 24(6):823-833. PubMed ID: 29785024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts.
    Shim JH; Greenblatt MB; Zou W; Huang Z; Wein MN; Brady N; Hu D; Charron J; Brodkin HR; Petsko GA; Zaller D; Zhai B; Gygi S; Glimcher LH; Jones DC
    J Clin Invest; 2013 Sep; 123(9):4010-22. PubMed ID: 23945236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone controls browning of white adipose tissue and protects from diet-induced obesity through Schnurri-3-regulated SLIT2 secretion.
    Li Z; Shi B; Li N; Sun J; Zeng X; Huang R; Bok S; Chen X; Han J; Yallowitz AR; Debnath S; Cung M; Ling Z; Zhong CQ; Hong Y; Li G; Koenen M; Cohen P; Su X; Lu H; Greenblatt MB; Xu R
    Nat Commun; 2024 Aug; 15(1):6697. PubMed ID: 39107299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of bone resorption in mice by Schnurri-3.
    Wein MN; Jones DC; Shim JH; Aliprantis AO; Sulyanto R; Lazarevic V; Poliachik SL; Gross TS; Glimcher LH
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8173-8. PubMed ID: 22573816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WNT-modulating gene silencers as a gene therapy for osteoporosis, bone fracture, and critical-sized bone defects.
    Oh WT; Yang YS; Xie J; Ma H; Kim JM; Park KH; Oh DS; Park-Min KH; Greenblatt MB; Gao G; Shim JH
    Mol Ther; 2023 Feb; 31(2):435-453. PubMed ID: 36184851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schnurri-3: a key regulator of postnatal skeletal remodeling.
    Jones DC; Wein MN; Glimcher LH
    Adv Exp Med Biol; 2007; 602():1-13. PubMed ID: 17966382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An angiogenic approach to osteoanabolic therapy targeting the SHN3-SLIT3 pathway.
    Yallowitz AR; Shim JH; Xu R; Greenblatt MB
    Bone; 2023 Jul; 172():116761. PubMed ID: 37030497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schnurri-3 controls osteogenic fate of Adipoq-lineage progenitors in bone marrow.
    Li Z; Zeng X; Shi B; Han J; Wu Z; Chen X; Zhang L; Li N; Greenblatt M; Huang J; Xu R
    J Orthop Translat; 2024 Mar; 45():168-177. PubMed ID: 38549808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Silencing of Recombinant Adeno-associated Virus Genomes by NP220 and the HUSH Complex.
    Das A; Vijayan M; Walton EM; Stafford VG; Fiflis DN; Asokan A
    J Virol; 2022 Feb; 96(4):e0203921. PubMed ID: 34878926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of postnatal bone mass by the zinc finger adapter protein Schnurri-3.
    Glimcher LH; Jones DC; Wein MN
    Ann N Y Acad Sci; 2007 Nov; 1116():174-81. PubMed ID: 18083927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
    Ulrich-Vinther M
    Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference-mediated silencing of Atp6i prevents both periapical bone erosion and inflammation in the mouse model of endodontic disease.
    Ma J; Chen W; Zhang L; Tucker B; Zhu G; Sasaki H; Hao L; Wang L; Ci H; Jiang H; Stashenko P; Li YP
    Infect Immun; 2013 Apr; 81(4):1021-30. PubMed ID: 23166162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine.
    Xia WF; Jung JU; Shun C; Xiong S; Xiong L; Shi XM; Mei L; Xiong WC
    J Bone Miner Res; 2013 Oct; 28(10):2122-35. PubMed ID: 23649480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation.
    Chen W; Gao B; Hao L; Zhu G; Jules J; MacDougall MJ; Wang J; Han X; Zhou X; Li YP
    J Periodontal Res; 2016 Oct; 51(5):647-60. PubMed ID: 26754272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3.
    Jones DC; Wein MN; Oukka M; Hofstaetter JG; Glimcher MJ; Glimcher LH
    Science; 2006 May; 312(5777):1223-7. PubMed ID: 16728642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteogenic differentiation of recombinant adeno-associated virus 2-transduced murine mesenchymal stem cells and development of an immunocompetent mouse model for ex vivo osteoporosis gene therapy.
    Kumar S; Mahendra G; Nagy TR; Ponnazhagan S
    Hum Gene Ther; 2004 Dec; 15(12):1197-206. PubMed ID: 15684696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.